Frontlight ResearchEarly access
Atrial fibrillation trials in Romania
4 of 9 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in RomaniaStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Where
- Bucharest, Craiova, Dobrosloveni, Jud. Maramures, Mures County, Pitesti, Rosu, Târgu Mureş
- Age
- 18 years and over
- People
- 2,628 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07430956 · EU 2025-521618-25-00 - Phase 3Not yet taking people in RomaniaStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Baia Mare, Brasov, Bucharest, Caracal, Craiova, Dobrosloveni, Iasi, Oradea, Pitesti, Rosu, Suceava, Târgu Mureş, Timisoara
- Age
- 18 years and over
- People
- 15,364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411 · EU 2025-521617-97-00 - Phase 3Taking peopleStudy to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Where
- Baloteşti, Brăila, Brasov, Bucharest, Cluj-Napoca, Craiova, Oradea, Pitesti, Pitestii, Satu Mare, Targu, Targu Mures, Târgu Mureş, Timisoara, Timișoara
- Age
- 65 years and over
- People
- 2,500 worldwide
- Run by
- Anthos Therapeutics, Inc.
See details and how to joinNCT05712200 · EU 2023-503224-66-00 - No phaseTaking peopleIntegrated Approach in Frail Older People with Atrial Fibrillation
- Where
- Bucharest
- Age
- 65 years and over
- People
- 1,250 worldwide
- Run by
- Heart Care Foundation
See details and how to joinNCT06775028